ADMED (Switzerland)

ADMED (Switzerland), commonly styled simply as admed, is a Swiss medical laboratory group organised as a private-law foundation (fondation de droit privé) based in the Canton of Neuchâtel. It describes itself as performing more than 3 million analyses per year across 7 sites, and its competences span clinical chemistry, haematology, immunology, microbiology, pathology and transfusion medicine. It is also presented as a Swiss reference centre for tick-borne diseases. The organisation serves both patients and healthcare professionals, offering sampling sites, results delivery, an analysis catalogue, pre- and post-analytical services and material ordering for professionals. admed is structured as a foundation composed of four departments, with more than 200 collaborators distributed across its 7 sites in the Canton of Neuchâtel. Its main laboratory and administrative locations include Fontaines (Rue de l'Industrie 7), Neuchâtel (Rue de la Maladière 45, on the RHNe Pourtalès site) and La Chaux-de-Fonds (Rue de Chasseral 20 and Boucle de Cydalise 16 for microbiology), with laboratory hours of 24/7 at the hospital sites. The foundation's departments include admed laboratoires, admed microbiologie, admed pathologie and immuno-haematology, each led by specialist directors. The foundation's history is rooted in several cantonal laboratory institutions. The Institut Neuchâtelois d'Anatomie Pathologique was created in 1969 by Dr Widgren, evolving from an autopsy service into histopathology and cytopathology diagnostics. The Institut Neuchâtelois de Microbiologie (INM) was created in 1970 on the initiative of the Canton of Neuchâtel, the communal hospitals and the Société Neuchâteloise de Médecine (SNM). The Fondation des Laboratoires des Hôpitaux Neuchâtelois (FLHN) dates from 1996. In 2006 the Fondation admed was created through the merger of three cantonal laboratories: FLHN, INAP and INM. Since then admed has expanded through collaborations and integrations, including the integration of the HNe Couvet laboratory in 2009 and collaboration with the Fertas laboratory in 2012. In 2016 admed pathologie celebrated its 50th anniversary and began a collaboration with the Centre du sein created in La Chaux-de-Fonds. During 2020 the organisation faced the global Covid-19 health crisis, with all teams working continuously for the community and participating in mass screening in the Canton of Neuchâtel. On 1 January 2021 admed broadened its competence by taking over "patient" analyses, blood product delivery and pre-transfusion tests previously performed by the SRNJTS, and created a transfusion medicine department. In 2022 it carried out a global redesign of its image and created a new website. Governance is provided by a general management team including David Pérez PhD as Director General, Pietro Cicero as Administrative and Financial Director, and departmental directors such as Samir Benabidallah (admed pathologie), Antony Croxatto (admed microbiologie) and Véronique Viette (admed laboratoires). The foundation emphasises quality management, holding ISO/IEC and FAMH accreditation and adhering to a laboratory code of conduct. As a private-law foundation, admed is not listed on any stock exchange and is owned by the foundation itself rather than by external shareholders.

The history of admed is a story of consolidation among cantonal laboratory institutions in the Canton of Neuchâtel. One of its roots is the Institut Neuchâtelois d'Anatomie Pathologique, created in 1969 by Dr Widgren. That institute evolved from an autopsy service into a service for histopathology and cytopathology diagnostics. A second root is the Institut Neuchâtelois de Microbiologie (INM), created in 1970 on the initiative of the Canton of Neuchâtel, the communal hospitals and the Société Neuchâteloise de Médecine (SNM). A third root is the Fondation des Laboratoires des Hôpitaux Neuchâtelois (FLHN), founded in 1996. In 2006 the Fondation admed was created through the merger of these three cantonal laboratories: FLHN, INAP and INM. This merger brought together laboratory medicine, pathology and microbiology under a single private-law foundation. The foundation subsequently expanded its footprint and collaborations. In 2009 it integrated the HNe Couvet laboratory. In 2012 it entered into a collaboration with the Fertas laboratory. In 2016 admed pathologie celebrated its 50th anniversary and began a collaboration with the Centre du sein created in La Chaux-de-Fonds. The year 2020 brought the global Covid-19 health crisis. According to the foundation's own history, all admed teams worked relentlessly for the community, and admed participated in mass screening in the Canton of Neuchâtel. On 1 January 2021 admed broadened its competence by taking over the "patient" analyses, the delivery of blood products and the pre-transfusion tests that had until then been performed by the SRNJTS. This step also led to the creation of a transfusion medicine department. In 2022 admed carried out a global redesign of its image and created a new website. Today admed presents itself as a private-law foundation active in the Canton of Neuchâtel, composed of four departments and with more than 200 collaborators across 7 sites. It performs more than 3 million analyses per year and covers clinical chemistry, haematology, immunology, microbiology, pathology and transfusion medicine. It is also described as a Swiss reference centre for tick-borne diseases. Its quality management is supported by ISO/IEC and FAMH accreditation and a laboratory code of conduct.

• 2022

  Global redesign of admed's image and creation of a new website.

• 2021

  Since 1 January 2021, admed has broadened its competence and taken over the "patient" analyses, blood product delivery and pre-transfusion tests previously performed by the SRNJTS; creation of a transfusion medicine department.

• 2020

  admed faces the global Covid-19 health crisis; all teams work relentlessly for the community and admed participates in mass screening in the Canton of Neuchâtel.

• 2016

  admed pathologie celebrates its 50th anniversary; collaboration between admed pathologie and the Centre du sein created in La Chaux-de-Fonds.

• 2012

  Collaboration between admed and the Fertas laboratory.

• 2009

  Integration of the HNe Couvet laboratory.

• 2006

  Creation of the Fondation admed through the merger of three cantonal laboratories: FLHN, INAP and INM.

• 1996

  Founding of the Fondation des Laboratoires des Hôpitaux Neuchâtelois (FLHN).

• 1970

  Creation of the Institut Neuchâtelois de Microbiologie (INM) on the initiative of the Canton of Neuchâtel, the communal hospitals and the Société Neuchâteloise de Médecine (SNM).

• 1969

  Creation of the Institut Neuchâtelois d'Anatomie Pathologique by Dr Widgren; it evolved from an autopsy service into histopathology and cytopathology diagnostics.

Swiss cantonal reference medical laboratory network and private-law foundation, serving patients and healthcare professionals with accredited, quality-assured analyses across multiple specialties.

• Clinical chemistry analyses

• Haematology analyses

• Immunology analyses

• Microbiology analyses

• Pathology diagnostics (histopathology and cytopathology)

• Transfusion medicine services

• Tick-borne disease diagnostics

• Pre- and post-analytical services

• Analysis catalogue for professionals

• Material ordering for professionals

1. 1admed – analyses & diagnostics médicauxadmed.ch
2. 2admed – analyses & diagnostics médicaux - Histoire d'admedadmed.ch
3. 3admed – analyses & diagnostics médicaux - À proposadmed.ch
4. 4admed – analyses & diagnostics médicaux - Organisation d'admedadmed.ch
5. 5ADMED (Switzerland) - Wikidatawikidata.org